These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32562682)

  • 1. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Mohr JP; Overbey JR; Hartmann A; Kummer RV; Al-Shahi Salman R; Kim H; van der Worp HB; Parides MK; Stefani MA; Houdart E; Libman R; Pile-Spellman J; Harkness K; Cordonnier C; Moquete E; Biondi A; Klijn CJM; Stapf C; Moskowitz AJ;
    Lancet Neurol; 2020 Jul; 19(7):573-581. PubMed ID: 32562682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
    Mohr JP; Parides MK; Stapf C; Moquete E; Moy CS; Overbey JR; Al-Shahi Salman R; Vicaut E; Young WL; Houdart E; Cordonnier C; Stefani MA; Hartmann A; von Kummer R; Biondi A; Berkefeld J; Klijn CJ; Harkness K; Libman R; Barreau X; Moskowitz AJ;
    Lancet; 2014 Feb; 383(9917):614-21. PubMed ID: 24268105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tailored multimodal treatment for unruptured brain arteriovenous malformation: comparison with a randomized trial of unruptured brain arteriovenous malformations.
    Ikedo T; Yamamoto EH; Mori H; Niwa A; Ozaki S; Kushi Y; Shimonaga K; Hamano E; Yamada K; Imamura H; Iihara K; Kataoka H
    Acta Neurochir (Wien); 2023 Dec; 165(12):3779-3785. PubMed ID: 37779178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial.
    CARE pilot trial collaboration
    Lancet Neurol; 2024 Jun; 23(6):565-576. PubMed ID: 38643777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NASSAU (New ASSessment of cerebral Arteriovenous Malformations yet Unruptured) Analysis: Are the Results From The ARUBA Trial Also Applicable to Unruptured Arteriovenous Malformations Deemed Suitable for Gamma Knife Surgery?
    Karlsson B; Jokura H; Yang HC; Yamamoto M; Martinez R; Kawagishi J; Guo WY; Beute G; Pan DHC; Aiyama H; Chung WY; Söderman M; Yeo TT
    Neurosurgery; 2019 Jul; 85(1):E118-E124. PubMed ID: 30295870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial.
    Link TW; Winston G; Schwarz JT; Lin N; Patsalides A; Gobin P; Pannullo S; Stieg PE; Knopman J
    World Neurosurg; 2018 Dec; 120():e1156-e1162. PubMed ID: 30218805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosurgery for Cerebral Arteriovenous Malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-Eligible Patients: A Multicenter Study.
    Ding D; Starke RM; Kano H; Mathieu D; Huang P; Kondziolka D; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Barnett GH; Lunsford LD; Sheehan JP
    Stroke; 2016 Feb; 47(2):342-9. PubMed ID: 26658441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients.
    Singfer U; Hemelsoet D; Vanlangenhove P; Martens F; Verbeke L; Van Roost D; Defreyne L
    Stroke; 2017 Dec; 48(12):3393-3396. PubMed ID: 29114088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample is More Common Post-ARUBA.
    Birnbaum LA; Straight M; Hegde S; Lacci JV; de Leonni Stanonik M; Mascitelli JR; McDougall CM; Caron JR
    World Neurosurg; 2020 May; 137():e343-e346. PubMed ID: 32032786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of radiosurgery for ARUBA-eligible arteriovenous malformations: a practical analysis over an appropriate follow-up period.
    Tonetti DA; Gross BA; Atcheson KM; Jankowitz BT; Kano H; Monaco EA; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2018 Jun; 128(6):1850-1854. PubMed ID: 28665253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcomes of A Randomized Trial of Unruptured Brain Arteriovenous Malformation-Eligible Unruptured Brain Arteriovenous Malformation Patients.
    Lang M; Moore NZ; Rasmussen PA; Bain MD
    Neurosurgery; 2018 Sep; 83(3):548-555. PubMed ID: 29040773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Knife Radiosurgery for ARUBA-Eligible Patients with Unruptured Brain Arteriovenous Malformations.
    Kim BS; Yeon JY; Kim JS; Hong SC; Shin HJ; Lee JI
    J Korean Med Sci; 2019 Sep; 34(36):e232. PubMed ID: 31538418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.
    Nerva JD; Mantovani A; Barber J; Kim LJ; Rockhill JK; Hallam DK; Ghodke BV; Sekhar LN
    Neurosurgery; 2015 May; 76(5):563-70; discussion570; quiz 570. PubMed ID: 25635891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients.
    Javadpour M; Al-Mahfoudh R; Mitchell PS; Kirollos R
    Br J Neurosurg; 2016 Dec; 30(6):619-622. PubMed ID: 27172987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for treating brain arteriovenous malformations in adults.
    Zuurbier SM; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD003436. PubMed ID: 31503327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional impairments for outcomes in a randomized trial of unruptured brain AVMs.
    Mohr JP; Overbey JR; von Kummer R; Stefani MA; Libman R; Stapf C; Parides MK; Pile-Spellman J; Moquete E; Moy CS; Vicaut E; Moskowitz AJ; Harkness K; Cordonnier C; Biondi A; Houdart E; Berkefeld J; Klijn CJM; Barreau X; Kim H; Hartmann A;
    Neurology; 2017 Oct; 89(14):1499-1506. PubMed ID: 28878048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention for A randomized trial of unruptured brain arteriovenous malformations (ARUBA) - Eligible patients: An evidence-based review.
    Hong CS; Peterson EC; Ding D; Sur S; Hasan D; Dumont AS; Chalouhi N; Jabbour P; Starke RM
    Clin Neurol Neurosurg; 2016 Nov; 150():133-138. PubMed ID: 27656780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases.
    Schramm J; Schaller K; Esche J; Boström A
    J Neurosurg; 2017 Apr; 126(4):1056-1063. PubMed ID: 27285541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations.
    Wong J; Slomovic A; Ibrahim G; Radovanovic I; Tymianski M
    Stroke; 2017 Jan; 48(1):136-144. PubMed ID: 27856955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in arteriovenous malformation management: the post-ARUBA era.
    Feghali J; Huang J
    Stroke Vasc Neurol; 2020; 5(1):34-39. PubMed ID: 32411406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.